Karen L. Smith, Global Head of R&D and CMO at Jazz Pharmaceuticals plc (JAZZ), bought 1,114 shares at $149.61 ($167K) on 2016-06-13, disclosed to the SEC on 2016-06-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.61 | 557 | $83K | 50.0% |
| 2 | $149.61 | 557 | $83K | 50.0% |
| Total | $149.61 avg | 1,114 | $167K | 100% |
| Filing → |
| XLRN | SELL | 2021-04-02 | $2.4M | — | Filing → |
| JAZZ | BUY | 2016-08-12 | $167K | — | Filing → |
| JAZZ | BUY | 2016-07-13 | $167K | — | Filing → |